| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | €84,9043 | -2,17 % | €1,23B | €180,11K | |
TMP Tompkins Financial Corporation | €83,0570 | +0,05 % | €1,23B | €29,83K | |
BRUN Boost Run Inc. Class A Common Stock | €16,5866 | +2,03 % | €1,23B | €1,18M | |
TWFG TWFG, Inc. Common Stock | €24,3219 | +3,57 % | €1,23B | €97,14K | |
PCT PureCycle Technologies, Inc. Common stock | €5,7726 | -5,86 % | €1,23B | €3,64M | |
REX REX American Resources Corp. | €37,9623 | +1,19 % | €1,23B | €89,64K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | €6,2515 | -5,68 % | €1,23B | €36,70K | |
BTT BlackRock Municipal 2030 Target Term Trust | €19,2506 | -0,57 % | €1,23B | €47,11K | |
ADNT Adient plc Ordinary Shares | €16,6678 | -0,71 % | €1,22B | €372,31K | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | €23,0818 | -0,04 % | €1,22B | €1,57M | |
| €30,9924 | -2,61 % | €1,22B | €920,46K | |
EMAT Evolution Metals & Technologies Corp. Common Stock | €2,8735 | +17,90 % | €1,22B | €930,65K | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | €14,4187 | +1,26 % | €1,22B | €54,94K | |
REPL Replimune Group, Inc. | €12,0070 | -5,20 % | €1,22B | €3,42M | |
HCSG Healthcare Services Group | €19,6525 | +0,22 % | €1,22B | €503,40K | |
